OCTOBER 29, 2025
5:00 PM - 6:00 PM
What you’ll learn during this webinar:
- How Europe’s fragmented HTA and reimbursement systems impact the speed and scale of diagnostic adoption in oncology.
- Practical lessons from startups, diagnostics companies, and pharma on overcoming access and reimbursement barriers.
- The ripple effect of delayed diagnostic uptake on precision oncology therapies, patient outcomes, and healthcare equity.
- Potential solutions and strategic approaches to navigate fragmentation and accelerate patient access to innovative diagnostics.
REGISTER NOW
HOST
Svetlana Nikic, PhD
Founder Precision Oncology Consulting
SPEAKERS
Tommi Lehtonen
CEO & Co-Founder
Hedera Dx
Hedera Dx
Prithwish Pal, PhD
Director of Global Product Marketing
Bio-Rad Laboratories
Bio-Rad Laboratories
Benjamin Gannon
Vice President Europe & Americas
Guardant Health
Guardant Health
Lee-Anne Zinetti
Executive Director, Precision Medicine Strategy - Oncology Portfolio
Novartis
Novartis
